Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 153 articles:
HTML format
Text format



Single Articles


    December 2017
  1. DAHLSTROM KR, Anderson KS, Field MS, Chowell D, et al
    Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Cancer. 2017;123:4886-4894.
    PubMed     Text format     Abstract available


  2. CHIN RI, Rao YJ, Hwang MY, Spencer CR, et al
    Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.
    Cancer. 2017;123:4594-4607.
    PubMed     Text format     Abstract available


    November 2017
  3. ALI SM, Ross JS, Wang K
    Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31132.
    PubMed     Text format    


  4. LUI VWY, To KF, Lo KW
    Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31131.
    PubMed     Text format    


  5. PRINTZ C
    First person: Maura L. Gillison, MD, PhD: The researcher who found the link between the human papillomavirus and head and neck cancers continues to lead new discoveries in the field.
    Cancer. 2017;123:4307.
    PubMed     Text format    


  6. LANG KUHS KA, Kreimer AR, Trivedi S, Holzinger D, et al
    Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Cancer. 2017;123:4382-4390.
    PubMed     Text format     Abstract available


  7. GUPTA A, Sonis ST, Schneider EB, Villa A, et al
    Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31095.
    PubMed     Text format     Abstract available


  8. HOBAN CW, Beesley LJ, Bellile EL, Sun Y, et al
    Individualized outcome prognostication for patients with laryngeal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31087.
    PubMed     Text format     Abstract available


  9. CHANDLER JB, Colunga M, Prasad ML, Callender GG, et al
    Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Cancer. 2017;125:865-875.
    PubMed     Text format     Abstract available


    October 2017
  10. HUANG WB, Chan JYW, Liu DL
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2017 Oct 26. doi: 10.1002/cncr.31031.
    PubMed     Text format     Abstract available


  11. BURTNESS B
    The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31059.
    PubMed     Text format    


  12. GLEBER-NETTO FO, Zhao M, Trivedi S, Wang J, et al
    Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31063.
    PubMed     Text format     Abstract available


  13. SHEN CJ, Hu C, Ladra MM, Narang AK, et al
    Socioeconomic factors affect the selection of proton radiation therapy for children.
    Cancer. 2017;123:4048-4056.
    PubMed     Text format     Abstract available


  14. WANG Z, Cheng Y, Abraham JM, Yan R, et al
    RNA sequencing of esophageal adenocarcinomas identifies novel fusion transcripts, including NPC1-MELK, arising from a complex chromosomal rearrangement.
    Cancer. 2017;123:3916-3924.
    PubMed     Text format     Abstract available


  15. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Text format     Abstract available


  16. CAPARROTTI F, Huang SH, Lu L, Bratman SV, et al
    Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Cancer. 2017;123:3691-3700.
    PubMed     Text format     Abstract available


  17. GRIFFITH CC, Schmitt AC, Pantanowitz L, Monaco SE, et al
    A pattern-based risk-stratification scheme for salivary gland cytology: A multi-institutional, interobserver variability study to determine applicability.
    Cancer. 2017;125:776-785.
    PubMed     Text format     Abstract available


  18. ROHILLA M, Singh P, Rajwanshi A, Gupta N, et al
    Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification.
    Cancer. 2017;125:767-775.
    PubMed     Text format     Abstract available


  19. ROSSI ED, Faquin WC, Baloch Z, Barkan GA, et al
    The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey.
    Cancer. 2017;125:757-766.
    PubMed     Text format     Abstract available


    September 2017
  20. SACCO AG, Cohen EE
    Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30970.
    PubMed     Text format    


  21. MITO JK, Alexander EK, Angell TE, Barletta JA, et al
    A modified reporting approach for thyroid FNA in the NIFTP era: A 1-year institutional experience.
    Cancer. 2017 Sep 13. doi: 10.1002/cncy.21907.
    PubMed     Text format     Abstract available


  22. BLUM MURPHY M, Xiao L, Patel VR, Maru DM, et al
    Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30953.
    PubMed     Text format     Abstract available


  23. SABA NF
    Refining the predictors of outcome in patients with resectable esophageal cancer.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30952.
    PubMed     Text format    


  24. NGUYEN MT, Hu J, Hastings KG, Daza EJ, et al
    Thyroid cancer mortality is higher in Filipinos in the United States: An analysis using National Mortality Records from 2003 through 2012.
    Cancer. 2017 Sep 7. doi: 10.1002/cncr.30958.
    PubMed     Text format     Abstract available


  25. RODEN DF, Schreiber D, Givi B
    Triple-modality treatment in patients with advanced stage tonsil cancer.
    Cancer. 2017;123:3269-3276.
    PubMed     Text format     Abstract available


    August 2017
  26. GRABOYES EM, Garrett-Mayer E, Ellis MA, Sharma AK, et al
    Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30939.
    PubMed     Text format     Abstract available


  27. ZUMSTEG ZS, Luu M, Yoshida EJ, Kim S, et al
    Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.
    Cancer. 2017 Aug 17. doi: 10.1002/cncr.30933.
    PubMed     Text format     Abstract available


  28. CHOI YM, Kim WG, Kwon H, Jeon MJ, et al
    Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data.
    Cancer. 2017 Aug 17. doi: 10.1002/cncr.30943.
    PubMed     Text format     Abstract available


  29. ALBERGOTTI WG, Jordan J, Anthony K, Abberbock S, et al
    A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Cancer. 2017;123:3132-3140.
    PubMed     Text format     Abstract available


  30. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    PubMed     Text format     Abstract available


  31. ROBIN TP, Jones BL, Gordon OM, Phan A, et al
    A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Cancer. 2017;123:3040-3049.
    PubMed     Text format     Abstract available


  32. BHATIA AK, Lee JW, Pinto HA, Jacobs CD, et al
    Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
    Cancer. 2017 Aug 7. doi: 10.1002/cncr.30920.
    PubMed     Text format     Abstract available


  33. ROOPER LM, Onenerk M, Siddiqui MT, Faquin WC, et al
    Nodular oncocytic hyperplasia: Can cytomorphology allow for the preoperative diagnosis of a nonneoplastic salivary disease?
    Cancer. 2017;125:627-634.
    PubMed     Text format     Abstract available


    July 2017
  34. SANDMAEL JA, Bye A, Solheim TS, Stene GB, et al
    Feasibility and preliminary effects of resistance training and nutritional supplements during versus after radiotherapy in patients with head and neck cancer: A pilot randomized trial.
    Cancer. 2017 Jul 31. doi: 10.1002/cncr.30901.
    PubMed     Text format     Abstract available


  35. RENSHAW AA, Gould EW
    Adequate sampling of multiple thyroid nodules by fine-needle aspiration.
    Cancer. 2017 Jul 31. doi: 10.1002/cncy.21904.
    PubMed     Text format     Abstract available


  36. CRAMER JD, Speedy SE, Ferris RL, Rademaker AW, et al
    National evaluation of multidisciplinary quality metrics for head and neck cancer.
    Cancer. 2017 Jul 20. doi: 10.1002/cncr.30902.
    PubMed     Text format     Abstract available


  37. AN Y, Park HS, Kelly JR, Stahl JM, et al
    The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:2762-2772.
    PubMed     Text format     Abstract available


  38. CHANDRASEKHARAPPA SC, Chinn SB, Donovan FX, Chowdhury NI, et al
    Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30802.
    PubMed     Text format     Abstract available


  39. OHORI NP, Wolfe J, Carty SE, Yip L, et al
    The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) resection diagnosis on the false-positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria.
    Cancer. 2017 Jul 5. doi: 10.1002/cncy.21892.
    PubMed     Text format     Abstract available


  40. MARINA NM, Liu Q, Donaldson SS, Sklar CA, et al
    Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Cancer. 2017;123:2551-2560.
    PubMed     Text format     Abstract available


  41. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Text format     Abstract available


    June 2017
  42. LEE AWM, Tung SY, Ng WT, Lee V, et al
    A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30850.
    PubMed     Text format     Abstract available


  43. SHERMAN EJ, Dunn LA, Ho AL, Baxi SS, et al
    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30861.
    PubMed     Text format     Abstract available


  44. DAVID JM, Ho AS, Luu M, Yoshida EJ, et al
    Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30843.
    PubMed     Text format     Abstract available


  45. WANG FH, Wang Y, Sun GP, Chen JH, et al
    Efficacy and safety of recombinant human lymphotoxin-alpha derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30845.
    PubMed     Text format     Abstract available


  46. CHO M, Oweity T, Brandler TC, Fried K, et al
    Distinguishing parathyroid and thyroid lesions on ultrasound-guided fine-needle aspiration: A correlation of clinical data, ancillary studies, and molecular analysis.
    Cancer. 2017 Jun 16. doi: 10.1002/cncy.21888.
    PubMed     Text format     Abstract available


  47. WALTERHOUSE DO, Pappo AS, Meza JL, Breneman JC, et al
    Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Cancer. 2017;123:2368-2375.
    PubMed     Text format     Abstract available


  48. KONG L, Zhang Y, Hu C, Guo Y, et al
    Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Cancer. 2017;123:2258-2267.
    PubMed     Text format     Abstract available


  49. LIN WC, Ding YF, Hsu HL, Chang JH, et al
    Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
    Cancer. 2017 Jun 13. doi: 10.1002/cncr.30823.
    PubMed     Text format     Abstract available


  50. ALI SM, Yao M, Yao J, Wang J, et al
    Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
    Cancer. 2017 Jun 5. doi: 10.1002/cncr.30781.
    PubMed     Text format     Abstract available


  51. ROSSI ED, Martini M, Cenci T, Capodimonti S, et al
    The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature.
    Cancer. 2017 Jun 5. doi: 10.1002/cncy.21884.
    PubMed     Text format     Abstract available


  52. JOHNSON DB, Sullivan RJ, Menzies AM
    Immune checkpoint inhibitors in challenging populations.
    Cancer. 2017;123:1904-1911.
    PubMed     Text format     Abstract available


  53. KIM Y, Lee SJ, Lee JY, Lee SH, et al
    Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
    Cancer. 2017;123:1958-1964.
    PubMed     Text format     Abstract available


  54. ONENERK AM, Pusztaszeri MP, Canberk S, Faquin WC, et al
    Triage of the indeterminate thyroid aspirate: What are the options for the practicing cytopathologist?
    Cancer. 2017;125.
    PubMed     Text format     Abstract available


    May 2017
  55. HANG JF, Westra WH, Cooper DS, Ali SZ, et al
    The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier.
    Cancer. 2017 May 24. doi: 10.1002/cncy.21879.
    PubMed     Text format     Abstract available


  56. CATENACCI DV, Ang A, Liao WL, Shen J, et al
    MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
    Cancer. 2017;123:1061-1070.
    PubMed     Text format     Abstract available


  57. MALM IJ, Fan CJ, Yin LX, Li DX, et al
    Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:1768-1777.
    PubMed     Text format     Abstract available


  58. GOEPFERT RP, Hutcheson KA, Lewin JS, Desai NG, et al
    Complications, hospital length of stay, and readmission after total laryngectomy.
    Cancer. 2017;123:1760-1767.
    PubMed     Text format     Abstract available


  59. LV JW, Chen YP, Huang XD, Zhou GQ, et al
    Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
    Cancer. 2017 May 10. doi: 10.1002/cncr.30775.
    PubMed     Text format     Abstract available


  60. PAI SI, Faquin WC
    Programmed cell death ligand 1 as a biomarker in head and neck cancer.
    Cancer. 2017 May 4. doi: 10.1002/cncy.21872.
    PubMed     Text format    


  61. NAIK KB, Liu Y, Goodman M, Gillespie TW, et al
    Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30763.
    PubMed     Text format     Abstract available


  62. FAKHRY C, Westra WH, Wang SJ, van Zante A, et al
    The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Cancer. 2017;123:1566-1575.
    PubMed     Text format     Abstract available


  63. SHIELD PW, Frost F, Finnimore JL, Wright RG, et al
    External quality assurance in nongynecologic cytology: The Australasian experience.
    Cancer. 2017;125:349-361.
    PubMed     Text format     Abstract available


    April 2017
  64. SHAH BR, Griffiths R, Hall SF
    Thyroid cancer incidence among Asian immigrants to Ontario, Canada: a population-based cohort study.
    Cancer. 2017 Apr 25. doi: 10.1002/cncr.30746.
    PubMed     Text format     Abstract available


  65. ZUMSTEG ZS, Lok BH, Ho AS, Drill E, et al
    The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Cancer. 2017;123:1345-1353.
    PubMed     Text format     Abstract available


  66. VIVERO M, Renshaw AA, Krane JF
    Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only.
    Cancer. 2017 Apr 7. doi: 10.1002/cncy.21858.
    PubMed     Text format     Abstract available


  67. BONGIOVANNI M, Mermod M, Canberk S, Saglietti C, et al
    Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
    Cancer. 2017 Apr 3. doi: 10.1002/cncy.21860.
    PubMed     Text format     Abstract available


  68. SABRA MM, Sherman EJ, Tuttle RM
    Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30690.
    PubMed     Text format     Abstract available


  69. D'SOUZA G, Robbins HA
    Sexual and relationship health among survivors of oropharyngeal or oral cavity squamous cell carcinoma.
    Cancer. 2017;123:1092-1094.
    PubMed     Text format    


    March 2017
  70. BERMAN TA, Schiller JT
    Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30588.
    PubMed     Text format     Abstract available


  71. HAJEK M, Sewell A, Kaech S, Burtness B, et al
    TRAF3/CYLD mutations identify a distinct subset of human papilloma virus-associated head and neck squamous cell carcinoma.
    Cancer. 2017 Mar 13. doi: 10.1002/cncr.30570.
    PubMed     Text format     Abstract available


  72. CHEN T, Zhang J, Chen Z, Van Waes C, et al
    Genetic alterations in TRAF3 and CYLD that regulate nuclear factor kappaB and interferon signaling define head and neck cancer subsets harboring human papillomavirus.
    Cancer. 2017 Mar 13. doi: 10.1002/cncr.30659.
    PubMed     Text format    


  73. BRANDLER TC, Zhou F, Liu CZ, Cho M, et al
    Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Cancer. 2017 Mar 10. doi: 10.1002/cncy.21848.
    PubMed     Text format     Abstract available


  74. SINHA P, Haughey BH, Kallogjeri D, Spitznagel EL, et al
    The role of postoperative chemoradiation for oropharyngeal carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:887-888.
    PubMed     Text format    


    February 2017
  75. LIU Z, Chang ET, Liu Q, Cai Y, et al
    Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30643.
    PubMed     Text format     Abstract available


  76. GRABOYES EM, Garrett-Mayer E, Sharma AK, Lentsch EJ, et al
    Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30651.
    PubMed     Text format     Abstract available


  77. ZEVALLOS JP, Mazul AL
    The complex relation between race, sex, and human papillomavirus status in head and neck cancer.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30619.
    PubMed     Text format    


  78. HUANG J, Fogg M, Wirth LJ, Daley H, et al
    Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
    Cancer. 2017 Feb 21. doi: 10.1002/cncr.30541.
    PubMed     Text format     Abstract available



  79. Immunotherapy drug improves survival for patients with head and neck cancer.
    Cancer. 2017;123:545.
    PubMed     Text format    


  80. DRAHOS J, Ricker W, Pfeiffer RM, Cook MB, et al
    Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
    Cancer. 2017;123:657-665.
    PubMed     Text format     Abstract available


  81. TABERNA M, Inglehart RC, Pickard RK, Fakhry C, et al
    Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer.
    Cancer. 2017 Feb 14. doi: 10.1002/cncr.30564.
    PubMed     Text format     Abstract available


  82. ZHAO L, Dias-Santagata D, Sadow PM, Faquin WC, et al
    Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21839.
    PubMed     Text format     Abstract available


  83. GAN TR, Nga ME, Lum JH, Wong WM, et al
    Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21823.
    PubMed     Text format     Abstract available


  84. GRABOYES EM, Zhan KY, Garrett-Mayer E, Lentsch EJ, et al
    Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2017 Feb 9. doi: 10.1002/cncr.30586.
    PubMed     Text format     Abstract available


  85. MANYAM BV, Garsa AA, Chin RI, Reddy CA, et al
    A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2017 Feb 7. doi: 10.1002/cncr.30601.
    PubMed     Text format     Abstract available


  86. YEN YC, Chang JH, Lin WC, Chiou JF, et al
    Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Cancer. 2017 Feb 2. doi: 10.1002/cncr.30565.
    PubMed     Text format     Abstract available


  87. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    PubMed     Text format     Abstract available


    January 2017
  88. WONG TH, Skanthakumar T, Nadkarni N, Nguyen HV, et al
    Survival of patients with head and neck squamous cell carcinoma by housing subsidy in a tiered public housing system.
    Cancer. 2017 Jan 30. doi: 10.1002/cncr.30557.
    PubMed     Text format     Abstract available


  89. JABBOUR J, Milross C, Sundaresan P, Ebrahimi A, et al
    Education and support needs in patients with head and neck cancer: A multi-institutional survey.
    Cancer. 2017 Jan 12. doi: 10.1002/cncr.30535.
    PubMed     Text format     Abstract available


  90. CHUANG SL, Su WW, Chen SL, Yen AM, et al
    Population-based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers.
    Cancer. 2017 Jan 5. doi: 10.1002/cncr.30517.
    PubMed     Text format     Abstract available


  91. HUTCHESON KA, Barrow MP, Barringer DA, Knott JK, et al
    Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation.
    Cancer. 2017;123:62-70.
    PubMed     Text format     Abstract available


  92. SHER DJ, Rusthoven CG, Khan SA, Fidler MJ, et al
    National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:273-282.
    PubMed     Text format     Abstract available


  93. COOPER JS, Fortpied C, Gregoire V, Le QT, et al
    The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:12-16.
    PubMed     Text format    


  94. COLLINS GS, Le Manach Y
    Nomograms need to be presented in full.
    Cancer. 2017;123:177-178.
    PubMed     Text format    


  95. CHOI HC, Xu W, Lee AW
    Reply to Nomograms need to be presented in full.
    Cancer. 2017;123:178-179.
    PubMed     Text format    


    December 2016
  96. PEZZI TA, Mohamed AS, Sheu T, Blanchard P, et al
    Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30493.
    PubMed     Text format     Abstract available


  97. ZUMSTEG ZS, Kim S, David JM, Yoshida EJ, et al
    Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30508.
    PubMed     Text format     Abstract available


  98. PENG H, Chen L, Li WF, Guo R, et al
    Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30520.
    PubMed     Text format     Abstract available


  99. RAMAKODI MP, Devarajan K, Blackman E, Gibbs D, et al
    Integrative genomic analysis identifies ancestry-related expression quantitative trait loci on DNA polymerase beta and supports the association of genetic ancestry with survival disparities in head and neck squamous cell carcinoma.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30457.
    PubMed     Text format     Abstract available


  100. BAUMAN JE, Cohen E, Ferris RL, Adelstein DJ, et al
    Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30449.
    PubMed     Text format     Abstract available


  101. BISHOP JA, French CA, Ali SZ
    Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
    Cancer. 2016;124:901-908.
    PubMed     Text format     Abstract available


    November 2016
  102. JIANG XS, Harrison GP, Datto MB
    Young investigator challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cancer. 2016 Nov 28. doi: 10.1002/cncy.21802.
    PubMed     Text format     Abstract available


  103. SOMNAY YR, Yu XM, Lloyd RV, Leverson G, et al
    Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.
    Cancer. 2016 Nov 2. doi: 10.1002/cncr.30403.
    PubMed     Text format     Abstract available


    October 2016
  104. TAJUDEEN BA, Taylor ZD, Garritano J, Cheng H, et al
    Dynamic optical contrast imaging as a novel modality for rapidly distinguishing head and neck squamous cell carcinoma from surrounding normal tissue.
    Cancer. 2016 Oct 20. doi: 10.1002/cncr.30338.
    PubMed     Text format     Abstract available


  105. HAUGEN BR
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
    Cancer. 2016 Oct 14. doi: 10.1002/cncr.30360.
    PubMed     Text format     Abstract available


  106. STOKES WA, Jones BL, Bhatia S, Oweida AJ, et al
    A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.
    Cancer. 2016 Oct 11. doi: 10.1002/cncr.30382.
    PubMed     Text format     Abstract available


    September 2016
  107. TAYLOR LJ, Greenberg CC, Lidor AO, Leverson GE, et al
    Utilization of surgical treatment for local and locoregional esophageal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2016 Sep 28. doi: 10.1002/cncr.30368.
    PubMed     Text format     Abstract available


  108. BIZZARRO T, Martini M, Capodimonti S, Straccia P, et al
    Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
    Cancer. 2016 Sep 26. doi: 10.1002/cncy.21777.
    PubMed     Text format     Abstract available


  109. BEADLE BM, Liao KP, Giordano SH, Garden AS, et al
    Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Cancer. 2016 Sep 23. doi: 10.1002/cncr.30350.
    PubMed     Text format     Abstract available


  110. CHAU NG, Haddad RI
    Antiangiogenic agents in head and neck squamous cell carcinoma: Tired of going solo.
    Cancer. 2016 Sep 20. doi: 10.1002/cncr.30352.
    PubMed     Text format    


  111. JIMENO A, Posner MR, Wirth LJ, Saba NF, et al
    A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Cancer. 2016 Sep 20. doi: 10.1002/cncr.30317.
    PubMed     Text format     Abstract available


    August 2016
  112. MAZUL AL, Taylor JM, Divaris K, Weissler MC, et al
    Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
    Cancer. 2016 Aug 29. doi: 10.1002/cncr.30312.
    PubMed     Text format     Abstract available


  113. JIMENO A, Machiels JP, Wirth L, Specenier P, et al
    Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30256.
    PubMed     Text format     Abstract available


  114. SHERMAN SI, Clary DO, Elisei R, Schlumberger MJ, et al
    Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30252.
    PubMed     Text format     Abstract available


  115. LUBITZ CC, Sosa JA
    The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients.
    Cancer. 2016 Aug 12. doi: 10.1002/cncr.30201.
    PubMed     Text format     Abstract available


  116. WARD MC, Reddy CA, Adelstein DJ, Koyfman SA, et al
    Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis.
    Cancer. 2016 Aug 9. doi: 10.1002/cncr.30214.
    PubMed     Text format     Abstract available


  117. NAGHAVI AO, Echevarria MI, Grass GD, Strom TJ, et al
    Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30212.
    PubMed     Text format     Abstract available


    July 2016
  118. DIVI V, Harris J, Harari PM, Cooper JS, et al
    Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).
    Cancer. 2016 Jul 15. doi: 10.1002/cncr.30204.
    PubMed     Text format     Abstract available


  119. KU GY, Kriplani A, Janjigian YY, Kelsen DP, et al
    Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.
    Cancer. 2016;122:2083-90.
    PubMed     Text format     Abstract available


  120. HORNE ZD, Glaser SM, Vargo JA, Ferris RL, et al
    Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Cancer. 2016;122:2021-30.
    PubMed     Text format     Abstract available


    June 2016
  121. YIN LX, Ha PK
    Genetic alterations in salivary gland cancers.
    Cancer. 2016;122:1822-31.
    PubMed     Text format     Abstract available


  122. GARDEN AS, Fuller CD, Rosenthal DI, William WN Jr, et al
    Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2016;122:1702-7.
    PubMed     Text format     Abstract available


  123. WEISS J, Grilley Olson J, Deal AM, Chera B, et al
    Using the galactose-alpha-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab.
    Cancer. 2016;122:1697-701.
    PubMed     Text format     Abstract available


    May 2016
  124. LIN CC, Fedewa SA, Prickett KK, Higgins KA, et al
    Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer.
    Cancer. 2016 May 31. doi: 10.1002/cncr.30122.
    PubMed     Text format     Abstract available


  125. WEISS JM, Bagley S, Hwang WT, Bauml J, et al
    Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma.
    Cancer. 2016 May 19. doi: 10.1002/cncr.30067.
    PubMed     Text format     Abstract available


  126. RETTIG EM, D'Souza G, Thompson CB, Koch WM, et al
    Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    Cancer. 2016 May 16. doi: 10.1002/cncr.30005.
    PubMed     Text format     Abstract available


  127. BIRON VL, Kostiuk M, Isaac A, Puttagunta L, et al
    Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Cancer. 2016;122:1544-51.
    PubMed     Text format     Abstract available


  128. CRACCHIOLO JR, Baxi SS, Morris LG, Ganly I, et al
    Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
    Cancer. 2016;122:1523-32.
    PubMed     Text format     Abstract available


  129. BELL D, Bell AH, Bondaruk J, Hanna EY, et al
    In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
    Cancer. 2016;122:1513-22.
    PubMed     Text format     Abstract available


  130. PATEL MA, Blackford AL, Rettig EM, Richmon JD, et al
    Rising population of survivors of oral squamous cell cancer in the United States.
    Cancer. 2016;122:1380-7.
    PubMed     Text format     Abstract available


  131. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    PubMed     Text format     Abstract available


    March 2016
  132. KUO P, Sosa JA, Burtness BA, Husain ZA, et al
    Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2016 Mar 28. doi: 10.1002/cncr.29962.
    PubMed     Text format     Abstract available


  133. AMINI A, Jones BL, McDermott JD, Serracino HS, et al
    Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29956.
    PubMed     Text format     Abstract available


  134. ROBERTS TJ, Colevas AD, Hara W, Holsinger FC, et al
    Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29932.
    PubMed     Text format     Abstract available


  135. SONG YS, Lim JA, Choi H, Won JK, et al
    Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29934.
    PubMed     Text format     Abstract available


  136. PRINTZ C
    Developments in precision medicine: Studies highlight new applications for cancer chemoprevention, treatment.
    Cancer. 2016;122:661-2.
    PubMed     Text format    


  137. ARMENIAN SH, Bhatia S
    Looking back to inform the future: Lesson learned from survivors of childhood cancer.
    Cancer. 2016;122:678-80.
    PubMed     Text format    


  138. FRIEDMAN DN, Chou JF, Oeffinger KC, Kleinerman RA, et al
    Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.
    Cancer. 2016;122:773-81.
    PubMed     Text format     Abstract available


  139. MOR V, Joyce NR, Cote DL, Gidwani RA, et al
    The rise of concurrent care for veterans with advanced cancer at the end of life.
    Cancer. 2016;122:782-90.
    PubMed     Text format     Abstract available


    February 2016
  140. MCDOWELL LJ, Young RJ, Johnston ML, Tan TJ, et al
    p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    Cancer. 2016 Feb 16. doi: 10.1002/cncr.29901.
    PubMed     Text format     Abstract available


  141. PAN JJ, Ng WT, Zong JF, Chan LL, et al
    Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Cancer. 2016;122:546-58.
    PubMed     Text format     Abstract available


  142. FRAKES JM, Naghavi AO, Demetriou SK, Strom TJ, et al
    Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Cancer. 2016;122:634-41.
    PubMed     Text format     Abstract available


  143. CAPOZZI LC, McNeely ML, Lau HY, Reimer RA, et al
    Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: Results from an exploratory randomized controlled exercise trial.
    Cancer. 2016 Feb 1. doi: 10.1002/cncr.29863.
    PubMed     Text format     Abstract available


    January 2016
  144. PRASAD ML, Vyas M, Horne MJ, Virk RK, et al
    NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Cancer. 2016 Jan 19. doi: 10.1002/cncr.29887.
    PubMed     Text format     Abstract available


    December 2015
  145. LIN SH, Zhang N, Godby J, Wang J, et al
    Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
    Cancer. 2015 Dec 30. doi: 10.1002/cncr.29857.
    PubMed     Text format     Abstract available


  146. VERDONCK-DE LEEUW IM, Cuijpers P, Leemans CR
    Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Cancer. 2015 Dec 22. doi: 10.1002/cncr.29850.
    PubMed     Text format    


  147. ROH JL, Kim SA
    Reply to pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Cancer. 2015 Dec 22. doi: 10.1002/cncr.29849.
    PubMed     Text format    


    October 2015
  148. WANG W, Su X, He K, Wang Y, et al
    Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Cancer. 2015 Oct 27. doi: 10.1002/cncr.29689.
    PubMed     Text format     Abstract available


  149. QIAN G, Jiang N, Wang D, Newman S, et al
    Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Cancer. 2015;121:3600-11.
    PubMed     Text format     Abstract available


  150. LAGERGREN J, Andersson G, Talback M, Drefahl S, et al
    Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site.
    Cancer. 2015 Oct 8. doi: 10.1002/cncr.29731.
    PubMed     Text format     Abstract available


  151. DAHLSTROM KR, Li G, Hussey CS, Vo JT, et al
    Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
    Cancer. 2015;121:3455-64.
    PubMed     Text format     Abstract available


    August 2015
  152. WANG LY, Roman BR, Migliacci JC, Palmer FL, et al
    Cost-effectiveness analysis of papillary thyroid cancer surveillance.
    Cancer. 2015 Aug 17. doi: 10.1002/cncr.29633.
    PubMed     Text format     Abstract available


    July 2015
  153. SAWKA AM, Straus S, Rodin G, Heus L, et al
    Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial.
    Cancer. 2015 Jul 20. doi: 10.1002/cncr.29548.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: